ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide-PMO Conjugates (PPMO) Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-32A18372
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Peptide PMO Conjugates PPMO Market Research Report 2024
BUY CHAPTERS

Global Peptide-PMO Conjugates (PPMO) Market Research Report 2024

Code: QYRE-Auto-32A18372
Report
November 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
WuXi AppTec
Creative Biogene
LifeTein
Epichem Ltd.
Biosynth
PYC Therapeutics
Asymchem
Ajinomoto
Hongene Biotech
Sinopep
Veliter
Sutura

Peptide-PMO Conjugates (PPMO) Market

Peptide-PMO Conjugates (PPMO) are antisense compounds composed of a phosphorodiamidate morpholino oligomer covalently conjugated to a cell-penetrating peptide. PPMO is next-generation PMO-based therapies in development and are specifically designed to increase tissue penetration compared with PMOs. They are water-soluble molecules that can seamlessly enter cells and bind to the target molecule. Because these are nuclease resistant and non-toxic at effective concentrations, PPMOs are good candidates for genetic diseases therapeutics.
The global Peptide-PMO Conjugates (PPMO) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Peptide-PMO Conjugates (PPMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide-PMO Conjugates (PPMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Peptide-PMO Conjugates (PPMO) include WuXi AppTec, Creative Biogene, LifeTein, Epichem, Biosynth, PYC Therapeutics, Asymchem Inc., Ajinomoto, Sutura, Hongene Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide-PMO Conjugates (PPMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide-PMO Conjugates (PPMO).
The Peptide-PMO Conjugates (PPMO) market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide-PMO Conjugates (PPMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide-PMO Conjugates (PPMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide-PMO Conjugates (PPMO) Market Report

Report Metric Details
Report Name Peptide-PMO Conjugates (PPMO) Market
by Type
  • CPP-PMO
  • Targeting Peptide-PMO
  • Other
by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company WuXi AppTec, Creative Biogene, LifeTein, Epichem, Biosynth, PYC Therapeutics, Asymchem Inc., Ajinomoto, Sutura, Hongene Biotech, Sinopep, Veliter
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peptide-PMO Conjugates (PPMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peptide-PMO Conjugates (PPMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peptide-PMO Conjugates (PPMO) Market report?

Ans: The main players in the Peptide-PMO Conjugates (PPMO) Market are WuXi AppTec, Creative Biogene, LifeTein, Epichem, Biosynth, PYC Therapeutics, Asymchem Inc., Ajinomoto, Sutura, Hongene Biotech, Sinopep, Veliter

What are the Application segmentation covered in the Peptide-PMO Conjugates (PPMO) Market report?

Ans: The Applications covered in the Peptide-PMO Conjugates (PPMO) Market report are Drug Delivery, Gene Therapy, Other

What are the Type segmentation covered in the Peptide-PMO Conjugates (PPMO) Market report?

Ans: The Types covered in the Peptide-PMO Conjugates (PPMO) Market report are CPP-PMO, Targeting Peptide-PMO, Other

Recommended Reports

Conjugates & PMO

APIs & Excipients

Therapeutic Technologies

1 Peptide-PMO Conjugates (PPMO) Market Overview
1.1 Product Definition
1.2 Peptide-PMO Conjugates (PPMO) by Type
1.2.1 Global Peptide-PMO Conjugates (PPMO) Market Value Comparison by Type (2024-2030)
1.2.2 CPP-PMO
1.2.3 Targeting Peptide-PMO
1.2.4 Other
1.3 Peptide-PMO Conjugates (PPMO) by Application
1.3.1 Global Peptide-PMO Conjugates (PPMO) Market Value by Application (2024-2030)
1.3.2 Drug Delivery
1.3.3 Gene Therapy
1.3.4 Other
1.4 Global Peptide-PMO Conjugates (PPMO) Market Size Estimates and Forecasts
1.4.1 Global Peptide-PMO Conjugates (PPMO) Revenue 2019-2030
1.4.2 Global Peptide-PMO Conjugates (PPMO) Sales 2019-2030
1.4.3 Global Peptide-PMO Conjugates (PPMO) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Peptide-PMO Conjugates (PPMO) Market Competition by Manufacturers
2.1 Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Peptide-PMO Conjugates (PPMO) Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Peptide-PMO Conjugates (PPMO), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Product Type & Application
2.7 Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Date of Enter into This Industry
2.8 Global Peptide-PMO Conjugates (PPMO) Market Competitive Situation and Trends
2.8.1 Global Peptide-PMO Conjugates (PPMO) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peptide-PMO Conjugates (PPMO) Players Market Share by Revenue
2.8.3 Global Peptide-PMO Conjugates (PPMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peptide-PMO Conjugates (PPMO) Market Scenario by Region
3.1 Global Peptide-PMO Conjugates (PPMO) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Peptide-PMO Conjugates (PPMO) Sales by Region: 2019-2030
3.2.1 Global Peptide-PMO Conjugates (PPMO) Sales by Region: 2019-2024
3.2.2 Global Peptide-PMO Conjugates (PPMO) Sales by Region: 2025-2030
3.3 Global Peptide-PMO Conjugates (PPMO) Revenue by Region: 2019-2030
3.3.1 Global Peptide-PMO Conjugates (PPMO) Revenue by Region: 2019-2024
3.3.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Region: 2025-2030
3.4 North America Peptide-PMO Conjugates (PPMO) Market Facts & Figures by Country
3.4.1 North America Peptide-PMO Conjugates (PPMO) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2030)
3.4.3 North America Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peptide-PMO Conjugates (PPMO) Market Facts & Figures by Country
3.5.1 Europe Peptide-PMO Conjugates (PPMO) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2030)
3.5.3 Europe Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peptide-PMO Conjugates (PPMO) Market Facts & Figures by Region
3.6.1 Asia Pacific Peptide-PMO Conjugates (PPMO) Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Peptide-PMO Conjugates (PPMO) Sales by Region (2019-2030)
3.6.3 Asia Pacific Peptide-PMO Conjugates (PPMO) Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Peptide-PMO Conjugates (PPMO) Market Facts & Figures by Country
3.7.1 Latin America Peptide-PMO Conjugates (PPMO) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2030)
3.7.3 Latin America Peptide-PMO Conjugates (PPMO) Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Peptide-PMO Conjugates (PPMO) Market Facts & Figures by Country
3.8.1 Middle East and Africa Peptide-PMO Conjugates (PPMO) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Peptide-PMO Conjugates (PPMO) Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2030)
4.1.1 Global Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2024)
4.1.2 Global Peptide-PMO Conjugates (PPMO) Sales by Type (2025-2030)
4.1.3 Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2019-2030)
4.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2030)
4.2.1 Global Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2024)
4.2.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Type (2025-2030)
4.2.3 Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2019-2030)
4.3 Global Peptide-PMO Conjugates (PPMO) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2030)
5.1.1 Global Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2024)
5.1.2 Global Peptide-PMO Conjugates (PPMO) Sales by Application (2025-2030)
5.1.3 Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2019-2030)
5.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2030)
5.2.1 Global Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2024)
5.2.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Application (2025-2030)
5.2.3 Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2019-2030)
5.3 Global Peptide-PMO Conjugates (PPMO) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 WuXi AppTec
6.1.1 WuXi AppTec Company Information
6.1.2 WuXi AppTec Description and Business Overview
6.1.3 WuXi AppTec Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 WuXi AppTec Peptide-PMO Conjugates (PPMO) Product Portfolio
6.1.5 WuXi AppTec Recent Developments/Updates
6.2 Creative Biogene
6.2.1 Creative Biogene Company Information
6.2.2 Creative Biogene Description and Business Overview
6.2.3 Creative Biogene Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Creative Biogene Peptide-PMO Conjugates (PPMO) Product Portfolio
6.2.5 Creative Biogene Recent Developments/Updates
6.3 LifeTein
6.3.1 LifeTein Company Information
6.3.2 LifeTein Description and Business Overview
6.3.3 LifeTein Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 LifeTein Peptide-PMO Conjugates (PPMO) Product Portfolio
6.3.5 LifeTein Recent Developments/Updates
6.4 Epichem
6.4.1 Epichem Company Information
6.4.2 Epichem Description and Business Overview
6.4.3 Epichem Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Epichem Peptide-PMO Conjugates (PPMO) Product Portfolio
6.4.5 Epichem Recent Developments/Updates
6.5 Biosynth
6.5.1 Biosynth Company Information
6.5.2 Biosynth Description and Business Overview
6.5.3 Biosynth Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biosynth Peptide-PMO Conjugates (PPMO) Product Portfolio
6.5.5 Biosynth Recent Developments/Updates
6.6 PYC Therapeutics
6.6.1 PYC Therapeutics Company Information
6.6.2 PYC Therapeutics Description and Business Overview
6.6.3 PYC Therapeutics Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 PYC Therapeutics Peptide-PMO Conjugates (PPMO) Product Portfolio
6.6.5 PYC Therapeutics Recent Developments/Updates
6.7 Asymchem Inc.
6.7.1 Asymchem Inc. Company Information
6.7.2 Asymchem Inc. Description and Business Overview
6.7.3 Asymchem Inc. Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Asymchem Inc. Peptide-PMO Conjugates (PPMO) Product Portfolio
6.7.5 Asymchem Inc. Recent Developments/Updates
6.8 Ajinomoto
6.8.1 Ajinomoto Company Information
6.8.2 Ajinomoto Description and Business Overview
6.8.3 Ajinomoto Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ajinomoto Peptide-PMO Conjugates (PPMO) Product Portfolio
6.8.5 Ajinomoto Recent Developments/Updates
6.9 Sutura
6.9.1 Sutura Company Information
6.9.2 Sutura Description and Business Overview
6.9.3 Sutura Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sutura Peptide-PMO Conjugates (PPMO) Product Portfolio
6.9.5 Sutura Recent Developments/Updates
6.10 Hongene Biotech
6.10.1 Hongene Biotech Company Information
6.10.2 Hongene Biotech Description and Business Overview
6.10.3 Hongene Biotech Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hongene Biotech Peptide-PMO Conjugates (PPMO) Product Portfolio
6.10.5 Hongene Biotech Recent Developments/Updates
6.11 Sinopep
6.11.1 Sinopep Company Information
6.11.2 Sinopep Description and Business Overview
6.11.3 Sinopep Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sinopep Peptide-PMO Conjugates (PPMO) Product Portfolio
6.11.5 Sinopep Recent Developments/Updates
6.12 Veliter
6.12.1 Veliter Company Information
6.12.2 Veliter Description and Business Overview
6.12.3 Veliter Peptide-PMO Conjugates (PPMO) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Veliter Peptide-PMO Conjugates (PPMO) Product Portfolio
6.12.5 Veliter Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peptide-PMO Conjugates (PPMO) Industry Chain Analysis
7.2 Peptide-PMO Conjugates (PPMO) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peptide-PMO Conjugates (PPMO) Production Mode & Process
7.4 Peptide-PMO Conjugates (PPMO) Sales and Marketing
7.4.1 Peptide-PMO Conjugates (PPMO) Sales Channels
7.4.2 Peptide-PMO Conjugates (PPMO) Distributors
7.5 Peptide-PMO Conjugates (PPMO) Customers
8 Peptide-PMO Conjugates (PPMO) Market Dynamics
8.1 Peptide-PMO Conjugates (PPMO) Industry Trends
8.2 Peptide-PMO Conjugates (PPMO) Market Drivers
8.3 Peptide-PMO Conjugates (PPMO) Market Challenges
8.4 Peptide-PMO Conjugates (PPMO) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
WuXi AppTec
Creative Biogene
LifeTein
Epichem Ltd.
Biosynth
PYC Therapeutics
Asymchem
Ajinomoto
Hongene Biotech
Sinopep
Veliter
Sutura
List of Tables
 Table 1. Global Peptide-PMO Conjugates (PPMO) Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Peptide-PMO Conjugates (PPMO) Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Peptide-PMO Conjugates (PPMO) Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Peptide-PMO Conjugates (PPMO) Sales (Kg) of Key Manufacturers (2019-2024)
 Table 5. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Peptide-PMO Conjugates (PPMO) Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Peptide-PMO Conjugates (PPMO) Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Peptide-PMO Conjugates (PPMO) Average Price (US$/g) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Peptide-PMO Conjugates (PPMO), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Product Type & Application
 Table 12. Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Peptide-PMO Conjugates (PPMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-PMO Conjugates (PPMO) as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peptide-PMO Conjugates (PPMO) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Peptide-PMO Conjugates (PPMO) Sales by Region (2019-2024) & (Kg)
 Table 18. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Region (2019-2024)
 Table 19. Global Peptide-PMO Conjugates (PPMO) Sales by Region (2025-2030) & (Kg)
 Table 20. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Region (2025-2030)
 Table 21. Global Peptide-PMO Conjugates (PPMO) Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Region (2019-2024)
 Table 23. Global Peptide-PMO Conjugates (PPMO) Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Region (2025-2030)
 Table 25. North America Peptide-PMO Conjugates (PPMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2024) & (Kg)
 Table 27. North America Peptide-PMO Conjugates (PPMO) Sales by Country (2025-2030) & (Kg)
 Table 28. North America Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Peptide-PMO Conjugates (PPMO) Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Peptide-PMO Conjugates (PPMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2024) & (Kg)
 Table 32. Europe Peptide-PMO Conjugates (PPMO) Sales by Country (2025-2030) & (Kg)
 Table 33. Europe Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Peptide-PMO Conjugates (PPMO) Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Peptide-PMO Conjugates (PPMO) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Peptide-PMO Conjugates (PPMO) Sales by Region (2019-2024) & (Kg)
 Table 37. Asia Pacific Peptide-PMO Conjugates (PPMO) Sales by Region (2025-2030) & (Kg)
 Table 38. Asia Pacific Peptide-PMO Conjugates (PPMO) Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Peptide-PMO Conjugates (PPMO) Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Peptide-PMO Conjugates (PPMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2024) & (Kg)
 Table 42. Latin America Peptide-PMO Conjugates (PPMO) Sales by Country (2025-2030) & (Kg)
 Table 43. Latin America Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Peptide-PMO Conjugates (PPMO) Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Peptide-PMO Conjugates (PPMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2024) & (Kg)
 Table 47. Middle East and Africa Peptide-PMO Conjugates (PPMO) Sales by Country (2025-2030) & (Kg)
 Table 48. Middle East and Africa Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Peptide-PMO Conjugates (PPMO) Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Peptide-PMO Conjugates (PPMO) Sales (Kg) by Type (2019-2024)
 Table 51. Global Peptide-PMO Conjugates (PPMO) Sales (Kg) by Type (2025-2030)
 Table 52. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2019-2024)
 Table 53. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2025-2030)
 Table 54. Global Peptide-PMO Conjugates (PPMO) Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Peptide-PMO Conjugates (PPMO) Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2019-2024)
 Table 57. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2025-2030)
 Table 58. Global Peptide-PMO Conjugates (PPMO) Price (US$/g) by Type (2019-2024)
 Table 59. Global Peptide-PMO Conjugates (PPMO) Price (US$/g) by Type (2025-2030)
 Table 60. Global Peptide-PMO Conjugates (PPMO) Sales (Kg) by Application (2019-2024)
 Table 61. Global Peptide-PMO Conjugates (PPMO) Sales (Kg) by Application (2025-2030)
 Table 62. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2019-2024)
 Table 63. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2025-2030)
 Table 64. Global Peptide-PMO Conjugates (PPMO) Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Peptide-PMO Conjugates (PPMO) Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2019-2024)
 Table 67. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2025-2030)
 Table 68. Global Peptide-PMO Conjugates (PPMO) Price (US$/g) by Application (2019-2024)
 Table 69. Global Peptide-PMO Conjugates (PPMO) Price (US$/g) by Application (2025-2030)
 Table 70. WuXi AppTec Company Information
 Table 71. WuXi AppTec Description and Business Overview
 Table 72. WuXi AppTec Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 73. WuXi AppTec Peptide-PMO Conjugates (PPMO) Product
 Table 74. WuXi AppTec Recent Developments/Updates
 Table 75. Creative Biogene Company Information
 Table 76. Creative Biogene Description and Business Overview
 Table 77. Creative Biogene Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 78. Creative Biogene Peptide-PMO Conjugates (PPMO) Product
 Table 79. Creative Biogene Recent Developments/Updates
 Table 80. LifeTein Company Information
 Table 81. LifeTein Description and Business Overview
 Table 82. LifeTein Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 83. LifeTein Peptide-PMO Conjugates (PPMO) Product
 Table 84. LifeTein Recent Developments/Updates
 Table 85. Epichem Company Information
 Table 86. Epichem Description and Business Overview
 Table 87. Epichem Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 88. Epichem Peptide-PMO Conjugates (PPMO) Product
 Table 89. Epichem Recent Developments/Updates
 Table 90. Biosynth Company Information
 Table 91. Biosynth Description and Business Overview
 Table 92. Biosynth Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 93. Biosynth Peptide-PMO Conjugates (PPMO) Product
 Table 94. Biosynth Recent Developments/Updates
 Table 95. PYC Therapeutics Company Information
 Table 96. PYC Therapeutics Description and Business Overview
 Table 97. PYC Therapeutics Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 98. PYC Therapeutics Peptide-PMO Conjugates (PPMO) Product
 Table 99. PYC Therapeutics Recent Developments/Updates
 Table 100. Asymchem Inc. Company Information
 Table 101. Asymchem Inc. Description and Business Overview
 Table 102. Asymchem Inc. Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 103. Asymchem Inc. Peptide-PMO Conjugates (PPMO) Product
 Table 104. Asymchem Inc. Recent Developments/Updates
 Table 105. Ajinomoto Company Information
 Table 106. Ajinomoto Description and Business Overview
 Table 107. Ajinomoto Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 108. Ajinomoto Peptide-PMO Conjugates (PPMO) Product
 Table 109. Ajinomoto Recent Developments/Updates
 Table 110. Sutura Company Information
 Table 111. Sutura Description and Business Overview
 Table 112. Sutura Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 113. Sutura Peptide-PMO Conjugates (PPMO) Product
 Table 114. Sutura Recent Developments/Updates
 Table 115. Hongene Biotech Company Information
 Table 116. Hongene Biotech Description and Business Overview
 Table 117. Hongene Biotech Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 118. Hongene Biotech Peptide-PMO Conjugates (PPMO) Product
 Table 119. Hongene Biotech Recent Developments/Updates
 Table 120. Sinopep Company Information
 Table 121. Sinopep Description and Business Overview
 Table 122. Sinopep Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 123. Sinopep Peptide-PMO Conjugates (PPMO) Product
 Table 124. Sinopep Recent Developments/Updates
 Table 125. Veliter Company Information
 Table 126. Veliter Description and Business Overview
 Table 127. Veliter Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 128. Veliter Peptide-PMO Conjugates (PPMO) Product
 Table 129. Veliter Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Peptide-PMO Conjugates (PPMO) Distributors List
 Table 133. Peptide-PMO Conjugates (PPMO) Customers List
 Table 134. Peptide-PMO Conjugates (PPMO) Market Trends
 Table 135. Peptide-PMO Conjugates (PPMO) Market Drivers
 Table 136. Peptide-PMO Conjugates (PPMO) Market Challenges
 Table 137. Peptide-PMO Conjugates (PPMO) Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peptide-PMO Conjugates (PPMO)
 Figure 2. Global Peptide-PMO Conjugates (PPMO) Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Peptide-PMO Conjugates (PPMO) Market Share by Type: 2023 & 2030
 Figure 4. CPP-PMO Product Picture
 Figure 5. Targeting Peptide-PMO Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Peptide-PMO Conjugates (PPMO) Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Peptide-PMO Conjugates (PPMO) Market Share by Application: 2023 & 2030
 Figure 9. Drug Delivery
 Figure 10. Gene Therapy
 Figure 11. Other
 Figure 12. Global Peptide-PMO Conjugates (PPMO) Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Peptide-PMO Conjugates (PPMO) Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Peptide-PMO Conjugates (PPMO) Sales (2019-2030) & (Kg)
 Figure 15. Global Peptide-PMO Conjugates (PPMO) Average Price (US$/g) & (2019-2030)
 Figure 16. Peptide-PMO Conjugates (PPMO) Report Years Considered
 Figure 17. Peptide-PMO Conjugates (PPMO) Sales Share by Manufacturers in 2023
 Figure 18. Global Peptide-PMO Conjugates (PPMO) Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Peptide-PMO Conjugates (PPMO) Players: Market Share by Revenue in Peptide-PMO Conjugates (PPMO) in 2023
 Figure 20. Peptide-PMO Conjugates (PPMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Peptide-PMO Conjugates (PPMO) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Peptide-PMO Conjugates (PPMO) Sales Market Share by Country (2019-2030)
 Figure 23. North America Peptide-PMO Conjugates (PPMO) Revenue Market Share by Country (2019-2030)
 Figure 24. United States Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Peptide-PMO Conjugates (PPMO) Sales Market Share by Country (2019-2030)
 Figure 27. Europe Peptide-PMO Conjugates (PPMO) Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Peptide-PMO Conjugates (PPMO) Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Peptide-PMO Conjugates (PPMO) Revenue Market Share by Region (2019-2030)
 Figure 35. China Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Peptide-PMO Conjugates (PPMO) Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Peptide-PMO Conjugates (PPMO) Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Peptide-PMO Conjugates (PPMO) Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Peptide-PMO Conjugates (PPMO) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Peptide-PMO Conjugates (PPMO) by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Peptide-PMO Conjugates (PPMO) by Type (2019-2030)
 Figure 54. Global Peptide-PMO Conjugates (PPMO) Price (US$/g) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Peptide-PMO Conjugates (PPMO) by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Peptide-PMO Conjugates (PPMO) by Application (2019-2030)
 Figure 57. Global Peptide-PMO Conjugates (PPMO) Price (US$/g) by Application (2019-2030)
 Figure 58. Peptide-PMO Conjugates (PPMO) Value Chain
 Figure 59. Peptide-PMO Conjugates (PPMO) Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global PPMO Peptide PMO Conjugates Therapy Market Research Report 2024
Global Cell Penetrating Peptide CPP PMO Conjugate Market Research Report 2024
Global PMO Conjugates Market Research Report 2024
Global Antibody PMO Conjugates Market Research Report 2024
Global Phosphorodiamidate Morpholino Oligomers PMO Market Research Report 2024
Global Peptide Drug Conjugates PDCs CDMO Service Market Research Report 2024
Global PMO Phosphorodiamidate Morpholino Oligomers Drug Market Research Report 2024
Global PMO Monomer Market Research Report 2024
Global Peptide Drug CDMO Market Research Report 2024
Global Peptide PNA Peptide nucleic acid Conjugate Market Research Report 2024
Global Peptide Conjugates Service Market Research Report 2024
Global Peptide CDMO Services Market Research Report 2025
Global Peptide API CDMO Services Market Research Report 2025
Global Lipid Nanoparticle CDMO Market Research Report 2025
Global CPP PNA Cell penetrating Peptide Peptide Nucleic Acid Conjugates Market Research Report 2024
Global Antibody drug Conjugates ADCs CMO and CDMO Market Research Report 2025
Global Oligonucleotide CDMO Market Research Report 2025
Peptide CDMO Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibody Drug Conjugate CDMO Market Research Report 2024
Global Peptide Antibody Conjugate PAC Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions